MAYBVM

10 11 OPENING LINES A LENS THAT OFFERS VISION AND COMFORT TO THOSE WHO THOUGHT ALL HOPE WAS LOST E yePrint Prosthetics LLC, a company dedicated to restoring vision and comfort to patients who have complex corneal irregularities, announces the clinical outcomes that have been achieved since the EyePrintPRO lens was first FDA- cleared less than two short years ago. The EyePrintPRO™ is a prosthetic scleral cover shell that improves vision by creating a new, smooth, refractive surface for the eye. It is similar to a type of contact lens known as a scleral lens.However, unlike other contact lenses, the EyePrintPRO™ is designed utilizing Elevation Specific Technology, a proprietary software that’s used to exactly match the unique irregularities of each individual eye. The process begins with an EyePrint Impression, which captures the precise curvatures of the entire ocular surface. Doctors then send the resulting impression to an EyePrint lab for 3-D scanning. The scanned data is then fed to a numerically controlled machin- ing system to produce a lens that matches the impression exactly and therefore fits the individual cornea and sclera perfectly. “The EyePrint is like a fingerprint — it’s completely individual,” says EyePrintPRO developer Dr. Christine Sindt, Clinical Professor of Ophthalmology and Visual Sciences at University of Iowa. Dr. Sindt has devoted her career to providing vision for patients with diseased and irregular corneas, including Teresa Sack, one of Dr. Sindt’s first EyePrintPRO patients. Teresa has had ten eye surgeries for conditions related to my- esthemia gravis, a condition she has struggled with for 27 years, which had left her with double vision, chronic pain and an inabil- ity to hold her head straight. “When I met Dr. Sindt, I didn’t expect that a contact lens could change my life,” says Teresa. “But even compared to all the surgeries, the EyePrintPRO™ has made the biggest difference.” Thanks to the EyePrintPRO, Teresa now has 20/20 vision, can hold her head in a straighter position, and has far less pain and discomfort. “Hundreds of thousands of people suffer from debili- tating corneal disease like Teresa does,” says Dr. Sindt. “These pa- tients have tried so many things and have gotten used to a string of disappointing outcomes.”